FRED BISCI TALKS: EXERCISE, LDL,HDL,HOMOCYSTEINE, B12, RAW, CHOLESTROL, TRIGLYCERIDES
|
|
Asymmetric dimethylarginine and outcomes in chronic kidney disease. $69.00 Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, reduces bioavailability of nitric oxide and induces endothelial dysfunction. This protein accumulates in chronic kidney disease (CKD) and may be involved in the pathophysiology of cardiovascular disease (CVD) in this high risk population. The Modification of Diet in Renal Disease Study was a randomized controlled… |
|
|
Plasma Asymmetric Dimethylarginine (Adma) in Relation to Cardiovascular Physiology & Risk Factors of Atherosclerosis (Acta Universitatis Tamperensis) $59.50 … |
|
|
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus / Tip … of Cardiology (Anadolu Kardiyoloji Dergisi) $9.95 This digital document is an article from The Anatolian Journal of Cardiology (Anadolu Kardiyoloji Dergisi), published by Thomson Gale on December 1, 2007. The length of the article is 5232 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with… |
Mail this post